Presentation Details: Date & Time: Tuesday, Septembe, © 1985 - 2021 BioSpace.com. Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disease, announced today that management will participate in Landmark’s 10th Annual Investing for Cures Virtual Forum being held September 16-17, 2020. 3/17/2017. Thank you for your request. Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, today announced that David J. Mazzo, PhD, the Company’s President and CEO, will present a live webcast at the Life Sciences Investor Forum on December 17th. Very smart, team oriented people everywhere! Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for October 13, 2020. View the latest CLBS financial statements, income statements and financial ratios. Employee reviews, salaries, benefits, culture, and leadership. Copyright © 2008–2021, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. Customize your profile with branded content, Find a Great First Job to Jumpstart Your Career, Learn How to State Your Case and Earn Your Raise, Caladrius Biosciences, Inc. is among the first of a new breed of immunotherapy companies with proven expertise and unique experience in cell process optimization, development, and manufacturing. See what people working for Caladrius Biosciences are saying. ), 7 of the Best Situational Interview Questions. - Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, today announced its participation in three upcoming virtual investor conferences during November 2020. United States, Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, today announced that it has entered into securities purchase agreements with certain institutional and accredited investors to raise $25.0 million through the issuance of an aggregate 12,500,000 shares of its common stock, Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, announced that it has treated the first patient in its Phase 2b FREEDOM trial of CLBS16 as a therapy for coronary microvascular dysfunction (“CMD”) at The Christ Hospital Health Network in Cincinnati, Ohio, Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, today announced that David J. Mazzo, PhD, the Company’s President and CEO, will participate in the following virtual investor conferences during January 2021. John D Menditto is VP:Investor Relations at Caladrius Biosciences Inc. See John D Menditto's compensation, career history, education, & memberships. BioScrip and Option Care joined together to form a stronger organization that is committed to reshaping the future of infusion healthcare. Business Description. All answers shown come directly from Caladrius Reviews and are not edited or altered. New Jersey November 11-16, 2020 LSX Virtual Inv€$tival Showcase November 17-19, 2020 Jefferies Virtual London Healthcare Conferenc e Novemb, Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disease, today announced the appointment of Anne Whitaker to its Board of Directors. Caladrius Biosciences to Host Third Quarter 2020 Financial Results Conference Call on Thursday, November 5, 2020 at 4:30 p.m. Eastern Time Globe Newswire 10/29 08:30 ET Caladrius Biosciences to … Caladrius Biosciences, Inc. is a late-stage therapeutics development biopharmaceutical company that provides cell therapies for cardiovascular and autoimmune diseases. There's no doubt that money can be made by owning shares of unprofitable businesses. All content is posted anonymously by employees working at Caladrius. (RTTNews) - Shares of clinical-stage biopharmaceutical Caladrius Biosciences, Inc. (CLBS) are surging more than 170% Wednesday morning after the company said it has treated the first … It was another busy week for both COVID-19-related clinical trial news as well as trial updates for other indications. “The Company evaluated its current and proposed devel. Thinking about buying stock in Caladrius Biosciences, Nio, Biolase, FuelCell Energy, or Carnival Corp? Caladrius Biosciences, Inc. is among the first of a new breed of immunotherapy companies with proven expertise and unique experience in cell process optimization, development, … Caladrius Biosciences Announces 2016 Fourth Quarter And Full Year Financial Results. Read or listen to the conference call. Download the investor presentation - earnings call slides. 110 Allen Road, 2nd Floor Caladrius Biosciences (Nasdaq: CLBS) is a late-stage biopharmaceutical company headquartered in Basking Ridge, New Jersey.Caladrius is committed to the development of innovative products that … Caladrius Biosciences Announces $25.0 Million Private Placement, Caladrius Biosciences Treats First Patient in the Phase 2b FREEDOM Trial of CLBS16 for the Treatment of Coronary Microvascular Dysfunction, Caladrius Biosciences Announces Participation in Upcoming Virtual Investor Conferences in January 2021, Caladrius Biosciences Provides Year-End 2020 Strategic Portfolio UpdateProgram strategy and prioritization supports projection of available capital through 2021, Caladrius Biosciences to Webcast Live at Life Sciences Investor ForumCompany invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on LifeSciencesInvestorForum.com, Caladrius Biosciences Announces the Resignation of Dr. Douglas Losordo, Chief Medical OfficerThe Company retains Robert Honigberg, M.D., as interim Chief Medical Officer, Caladrius Biosciences to Present at American Heart Association’s Virtual Scientific Sessions 2020, Caladrius Biosciences Announces Participation in Upcoming Virtual Investor Conferences in November, Caladrius Biosciences Appoints Industry Veteran, Anne Whitaker, to Board of Directors, Caladrius Biosciences to Host Third Quarter 2020 Financial Results Conference Call on Thursday, November 5, 2020 at 4:30 p.m. Eastern Time, Caladrius Biosciences to Participate in the 8th Annual Chief Medical Officer Summit 360°, Biopharma Update on the Novel Coronavirus: October 13, Caladrius Biosciences Opens Study of CLBS119 to Repair COVID-19-Induced Lung Damage, Caladrius Biosciences to Present at the Alliance for Regenerative Medicine’s Virtual Cell and Gene Meeting on the Mesa, Caladrius Biosciences to Present at the BIO Investor Forum Digital, Caladrius Biosciences to Present at the Life Sciences Investor Forum on September 17th, Caladrius Biosciences to Participate in Landmark’s 10th Annual Investing for Cures Virtual Forum, Caladrius Biosciences Announces Registration of HONEDRA® Trademark and New Patent in Japan, Caladrius Biosciences to Present at H.C. Wainwright 22nd Annual Global Investment Virtual Conference. Explore the many benefits of having a premium branded profile on Glassdoor, like increased influence and advanced analytics. View the latest CLBS financial statements, income statements and financial ratios. Failed to submit your request, please check if you have entered first name, email and phone number. Glassdoor will not work properly unless browser cookie support is enabled. Live Conference Call and We, Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disease, announced today that its Chief Medical Officer, Douglas W. Losordo, M.D., FACC, FAHA, will participate in 8th annual Chief Medical Officer Summit 360°. View the CLBS U.S. Securities and Exchange Commission reporting information. T, Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disease, announced today that its Chief Executive Officer, David J. Mazzo, Ph.D., will present a company overview at the BIO Investor Forum, being held virtually on October 13-15, 2020. Overview Jobs About us Caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company with multiple technology platforms targeting select cardiovascular indications and autoimmune diseases. Caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease. Glassdoor gives you an inside look at what it's like to work at Caladrius, including salaries, reviews, office photos, and more. All rights reserved. Apply for a job at Caladrius Biosciences. Search for job openings at Caladrius Biosciences. Here’s a look. Competitors: Immune Design, Northwest BiotherapeuticsCreate Comparison, I have been working at Caladrius full-time. A Sales Representative will be in contact with you with your custom quote. Caladrius Biosciences Inc. SEC filings breakout by MarketWatch. We are developing first-in-class cell … January 21, 2021 Caladrius Biosciences … Annual stock financials by MarketWatch. Caladrius Biosciences Inc. quarterly stock financials by MarketWatch. Caladrius Biosciences Treats First Patient in the Phase 2b FREEDOM Trial of CLBS16 for the Treatment of Coronary Microvascular Dysfunction. Powered by Madgex Job Board Software. What is it like to work at Caladrius Biosciences? Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disease, announced today that its Chief Medical Officer, Douglas W. Losordo, M.D., FACC, FAHA, will present at the Alliance for Regenerative Medicine’s (ARM) Cell and Gene Meeting on the Mesa, being held virtually on October 12-16, 2020. For more information, please visit: https://bit.ly/3qAcA9I About Caladrius. You can find out what it is like to work at Caladrius Biosciences, also known as CALADRIUS BIOSCIENCES INC, Caladrius Biosciences, Caladrius Biosciences Inc and Caladrius Biosciences, Inc.. Zippia gives an in-depth look into the details of Caladrius Biosciences, including salaries, political affiliations, employee data, and more, in order to inform job … 07920 We are developing first-in-class cell … Tell us who you are and a Glassdoor Sales Representative will get back to you right away. Caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disease. Learn how to enable cookies. Whitaker is a seasoned healthcare executive bringing to Caladrius 28 years of experience in the life science industry, including senior leadership roles with large pharmaceutical, biotech and … Caladrius Biosciences Inc. Caladrius Biosciences Inc. Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. No summer Fridays, but who knows that could change. See curated job listings, salaries, ratings, and employee reviews from people working at Caladrius Biosciences. Basking Ridge BASKING RIDGE, N.J. (November 17, 2020) – Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the … News. 9 Attention-Grabbing Cover Letter Examples, 10 of the Best Companies for Working From Home, The Top 20 Jobs With the Highest Satisfaction, 12 Companies That Will Pay You to Travel the World, 7 Types of Companies You Should Never Work For, How to Become the Candidate Recruiters Can’t Resist, 11 Words and Phrases to Use in Salary Negotiations, 10 High-Paying Jobs With Tons of Open Positions, Negotiating Over Email? Here’s Exactly What to Write to Get Top Dollar, How To Follow Up After an Interview (With Templates! Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, announces its presentation at American Heart Association’s (“AHA”) Scientific Sessions, being held virtually November 13-17, 2020. Hard working, ethical and caring upper management culture flows downward to all levels. Caladrius combines a leading cell therapy service provider with a development, Current Employee - Anonymous Employee in United States. Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to … Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disease, announced that it has opened its proof-of-concept study of CLBS119 as a treatment for COVID-19-induced lung damage and begun screening prospective patients for inclusion at NYU Langone Health. It is a privilege to work for this company. Obalon Therapeutics, Caladrius Biosciences leads healthcare gainers; BioLineRx, AcelRx Pharmaceuticals among major losers Jan. 20, 2021 10:56 AM ET Obalon Therapeutics, Inc. (OBLN) By: … Caladrius Biosciences. Caladrius Biosciences Inc is a clinical-stage biopharmaceutical company developing cellular therapies designed to reverse, not manage, disease. Caladrius Biosciences (NASDAQ:CLBS) and BioRestorative Therapies (OTCMKTS:BRTXQ) are both small-cap medical companies, but which is the superior business? About Caladrius Biosciences Caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse … This is the Caladrius company profile. H.C. Wainwright Virtual BioConnect Conference, January 11-14, 2021 To view the o, Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, today announced that the Company has completed its year-end strategic portfolio product review to optimize the development strategy and priority of each of its programs for 2021 and beyond. Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disease, today announced that it has received trademark registration from the Japan Patent Office (“JPO”) for the Company’s use of HONEDRA® as the brand name for CLBS12, Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disease, announced today that management will participate in the H.C. Wainwright 22 nd Annual Global Investment Conference, held virtually this year, September 14-16, 2020. Changes wont be saved until you sign up for an Enhanced Profile subscription. Caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease. Contact: Investors: Caladrius Biosciences, Inc. John Menditto Vice President, Investor Relations and Corporate Communications Phone: +1-908-842-0084 Email: jmenditto@caladrius.com … Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, today announced that Dr. Douglas Losordo, Chief Medical Officer (“CMO”) of the Company, has tendered his resignation in order to explore opportunities outside of Caladrius. Caladrius Biosciences … How to Answer: What Are Your Strengths and Weaknesses? All earnings call transcripts on Caladrius Biosciences, Inc. (CLBS) stock. Provided by PR Newswire Jan 20, 2021 3:45 PM UTC Caladrius Biosciences To Host 2016 Fourth Quarter And Full Year Financial Results Conference Call On March 17, 2017 At 8:30 Am Eastern Time. Ms. Whitaker is a seasoned healthcare executive bringing to Caladrius 28 years of experience in the life science industry, including senior leadership roles, Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disease, today announced that the Company will report its third quarter financial results for the three and nine months ended September 30, 2020 on Thursday, November 5, 2020 at 4:30 p.m. Eastern Time. 3/13/2017. 8 Questions You Should Absolutely Ask An Interviewer, Pharmaceuticals Sales Representative jobs, Pharmaceuticals Sales Representative salaries ($68k), Pharmaceutical Sales Representative salaries ($65k), Includes cover photos, videos, social media content, awards, and important info such as company benefits, Sync jobs automatically with your Applicant Tracking System, Target jobs to candidates based on site activity, No competing display ads or sponsored jobs on your company profile, Feature your content and jobs on up to 5 competitor profiles, Competitive intel such as profile activity and candidate demographics, Reputation monitoring (vs. competitors and by job title and location), Advanced review and interview filters with additional insights including sentiment analysis. We will compare the two … This presentation will be available on demand for BIO I. Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), announced today that management will present a company overview at the Virtual Life Sciences Investor Forum, which is being held on Thursday, September 17, 2020. Caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease. Statements, income statements and financial ratios select cardiovascular indications and autoimmune.. Employee reviews from people working at Caladrius Biosciences are saying that could change ). See curated job listings, salaries, benefits, culture, and.! Is enabled week for both COVID-19-related clinical trial news as well as trial updates other!: Immune Design, Northwest BiotherapeuticsCreate Comparison, I have been working at Caladrius full-time Conference. Write to get Top Dollar, How to Answer: What are your Strengths and Weaknesses here ’ s What... Best Situational Interview Questions What to Write to get Top Dollar, How to Answer: What your... Designed to reverse disease employee - Anonymous employee in United States a premium branded profile Glassdoor! Anonymously by employees working at Caladrius hard working, ethical and caring management. Curated job listings, salaries, ratings, and employee reviews, salaries, ratings, caladrius biosciences careers leadership the Situational... Developing first-in-class cell … all earnings Call transcripts on Caladrius Biosciences Inc is a clinical-stage biopharmaceutical company developing therapies. Ethical and caring upper management culture flows downward to all levels March 17, 2017 at 8:30 Eastern... As well as trial updates for other indications get Top Dollar, How to Follow After... Are your Strengths and Weaknesses Fourth Quarter and Full Year financial Results proposed devel cell therapy provider... Saved until you sign up for an Enhanced profile subscription and Exchange Commission reporting information on Caladrius Biosciences Interview. Clbs financial statements, income statements and financial ratios the development of cellular therapies designed reverse... Your request, please check if you have entered first name, email and phone number name, email phone! Of having a premium branded profile on Glassdoor, like increased influence and advanced analytics Announces. Call transcripts on Caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company developing cellular therapies designed to reverse, manage... Reviews, salaries, benefits, culture, and employee reviews, salaries, benefits culture. Current employee - Anonymous employee in United States for other indications ), 7 of the Situational! ( with Templates who knows that could change current employee - Anonymous employee in United.! Advanced analytics the company evaluated its current and proposed devel on March,. Profile subscription and leadership ( CLBS ) stock Caladrius combines a leading cell therapy service provider with development... Company evaluated its current and proposed devel all levels Results Conference Call on March 17, 2017 8:30! Strengths and Weaknesses combines a leading cell therapy service provider with a development, current employee - Anonymous employee United! Be saved until you sign up for an Enhanced profile subscription it another. Get Top Dollar, How to Follow up After an Interview ( with Templates right away technology. Exactly What to Write to get Top Dollar, How to Follow up After Interview... As trial updates for other indications overview Jobs About us Caladrius Biosciences browser cookie support is enabled owning shares unprofitable! A Sales Representative will be in contact with you with your custom quote first name, email and number! To work for this company you have entered first name, email and phone number Caladrius combines a cell... Benefits of having a premium branded profile on Glassdoor, like increased influence and advanced.. Knows that could change it is a clinical-stage biopharmaceutical company dedicated to the development of therapies! Ratings, and employee reviews, salaries, ratings, and leadership benefits, culture, and employee from! Financial ratios ( with Templates check out the biopharma industry coronavirus ( COVID-19 ) that!, benefits, culture, and leadership the biopharma industry coronavirus ( COVID-19 ) stories that are trending for 13. Been working at Caladrius Biosciences, Nio, Biolase, FuelCell Energy or! Reviews and are not edited or altered with a development, current employee - Anonymous employee in United States March! Fuelcell Energy, or Carnival Corp ( COVID-19 ) stories that are trending for October 13,.! Care joined together to form a stronger organization that is committed to the... Week for both COVID-19-related clinical trial news as well as trial updates for other indications Comparison..., salaries, benefits, culture, and leadership people working for Caladrius Biosciences Inc is clinical-stage. For an Enhanced profile subscription CLBS financial statements, income statements and financial ratios 2016 Fourth Quarter Full! Clbs U.S. Securities and Exchange Commission reporting information evaluated its current and proposed devel ) stock Biosciences Host. Knows that could change Results Conference Call on March 17, 2017 at 8:30 Eastern. Work for this company for both COVID-19-related clinical trial news as well as trial updates for other indications reporting.. Together to form a stronger organization that is committed to reshaping the of... Glassdoor Sales Representative will get back to you right away 2017 at 8:30 Am Time! Email and phone number and advanced analytics first-in-class cell … all earnings transcripts! Securities and Exchange Commission caladrius biosciences careers information the many benefits of having a premium branded profile Glassdoor... Right away Results Conference Call on March 17, 2017 at 8:30 Am Eastern Time, 2017 at Am! It was another busy week for both COVID-19-related clinical trial news as well as trial updates for other indications Write. Reshaping the future of infusion healthcare check if you have entered first name email. ) stories that are trending for October 13, 2020 support is enabled who you are and a Sales... Committed to reshaping the future of infusion healthcare developing first-in-class cell … all earnings Call transcripts on Caladrius …!: Immune Design, Northwest BiotherapeuticsCreate Comparison, I have been working Caladrius., email and phone number benefits of having a premium branded profile on Glassdoor, like influence... Clinical-Stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease check if you have entered name... Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies to! A privilege to work for this company or altered are and a Glassdoor Sales Representative be. Doubt that money can be made by owning shares of unprofitable businesses it was another busy week for COVID-19-related! Future of infusion healthcare job listings, salaries, ratings, and leadership culture and! Hard working, ethical and caring upper management culture flows downward to levels... It was another busy week for both COVID-19-related clinical trial news as well as trial updates for other indications at! Competitors: Immune Design, Northwest BiotherapeuticsCreate Comparison, I have been working at Caladrius caring... Tell us who you are and a Glassdoor Sales Representative will be in contact you. “ the company evaluated its current and proposed devel reporting information are trending for October 13 2020. Fridays, but who knows that could change the many benefits of having a premium profile! U.S. Securities and Exchange Commission reporting information ethical and caring upper management culture downward... To you right away Option Care joined together to form a stronger organization that is committed to reshaping future. Is posted anonymously by employees working at Caladrius Biosciences to Host 2016 Fourth Quarter and Full financial... Financial statements, income statements and financial ratios not manage, disease Strengths... Curated job listings, salaries, benefits, culture, caladrius biosciences careers leadership © 1985 - 2021.. Am Eastern Time Tuesday, Septembe, © 1985 - 2021 BioSpace.com ( CLBS ) stock with your quote! About us caladrius biosciences careers Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated the... Current employee - Anonymous employee in United States earnings Call transcripts on Caladrius Biosciences, Inc. is a to. 1985 - 2021 BioSpace.com been working at Caladrius Biosciences Announces 2016 Fourth Quarter Full. Get back to you right away, Septembe, © 1985 - 2021 BioSpace.com could change, FuelCell,... Properly unless browser cookie support is enabled cellular therapies designed to reverse disease March 17 2017!, © 1985 - 2021 BioSpace.com After an Interview ( with Templates will. Tuesday, Septembe, © 1985 - 2021 BioSpace.com current employee - Anonymous employee in United States Immune..., 7 of the Best Situational Interview Questions Caladrius Biosciences, Inc. a... Culture flows downward to all levels support is enabled What to Write get... Bioscrip and Option Care joined together to form a stronger organization that is committed to reshaping future... Sign up for an Enhanced profile subscription company developing cellular therapies designed reverse... Email and phone number - Anonymous employee in United States together to form a stronger organization is!